Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs

Figure 1

Strategy of a gene expression signature-based drug screen.

A gene expression signature that reflects a clinical/biological phenotype is used to profile the NCI-60 panel to identify cells that exhibit the phenotype of interest. The predicted probability for the signature is correlated against the sensitivity to over 40,000 (21,603 after filtering) compounds to identify compounds that appear to be effective in cells exhibiting the phenotype.

Figure 1

doi: https://doi.org/10.1371/journal.pone.0006772.g001